Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mounjaro (tirzepatide) is the first dual GIP and GLP-1 receptor agonist, representing a distinct pharmacological class from exendin-4-based therapies
JCI Insight 5(6):e133429 Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1
When these demands exceed available biochemical reserve, mitochondrial energy and recovery from stress may become less efficient
Fernandez-Millan E, Martin MA, Goya L, Lizarraga-Mollinedo E, Escriva F, Ramos S, et al
ATTAIN-MAINTAIN Trial Study Design In the present study, researchers evaluated the safety and efficacy of orforglipron in body weight maintenance after treatment with injectables
Reach out to your healthcare provider for more guidance
US$ 21.48
US$ 21.37
US$ 19.99
US$ 26.27
